Thrombin_NN
generation_NN
by_IN
apoptotic_JJ
vascular_JJ
smooth_JJ
muscle_NN
cells_NNS
._.

Thrombin_NN
activation_NN
requires_VBZ
assembly_NN
of_IN
a_DT
prothrombinase_NN
complex_NN
of_IN
activated_VBN
coagulation_NN
factors_NNS
on_IN
an_DT
anionic_JJ
phospholipid_JJ
surface_NN
,_,
classically_RB
provided_VBN
by_IN
activated_VBN
platelets_NNS
._.

We_PRP
have_VBP
previously_RB
shown_VBN
that_IN
anionic_JJ
phosphatidylserine_NN
is_VBZ
exposed_VBN
by_IN
rat_NN
vascular_JJ
smooth_JJ
muscle_NN
cells_NNS
-LRB-_-LRB-
VSMCs_NNS
-RRB-_-RRB-
undergoing_VBG
apoptosis_NN
after_IN
serum_NN
withdrawal_NN
._.

In_IN
this_DT
study_NN
,_,
using_VBG
a_DT
chromogenic_JJ
assay_NN
,_,
we_PRP
have_VBP
shown_VBN
thrombin_NN
generation_NN
by_IN
apoptotic_JJ
VSMCs_NNS
expressing_VBG
c-myc_NN
-LRB-_-LRB-
VSMC-myc_NN
-RRB-_-RRB-
with_IN
an_DT
area_NN
under_IN
the_DT
thrombin-generation_NN
curve_NN
-LRB-_-LRB-
AUC_NN
-RRB-_-RRB-
of_IN
305_CD
+_CC
\/_CD
-_CC
17_CD
nmol_NN
x_NN
min\/L_NN
and_CC
a_DT
peak_JJ
thrombin_NN
-LRB-_-LRB-
PT_NN
-RRB-_-RRB-
of_IN
154_CD
+_NN
\/_:
-_:
9_CD
nmol\/L_NN
._.

The_DT
thrombin-generating_JJ
potential_NN
of_IN
the_DT
apoptotic_JJ
VSMC-myc_JJ
cells_NNS
was_VBD
greater_JJR
than_IN
that_DT
of_IN
unactivated_JJ
platelets_NNS
-LRB-_-LRB-
P_NN
=_JJ
.003_CD
for_IN
AUC_NN
;_:
P_NN
=_JJ
.0002_NN
for_IN
PT_NN
-RRB-_-RRB-
and_CC
similar_JJ
to_TO
calcium-ionophore_JJ
activated_JJ
platelets_NNS
-LRB-_-LRB-
AUC_NN
of_IN
332_CD
+_NN
\/_:
-_:
15_CD
nmol_CD
x_CC
min\/L_CD
,_,
P_NN
=_JJ
.3_NN
;_:
PT_NN
of_IN
172_NN
+_CC
\/_CD
-_TO
8_CD
nmol\/L_NN
,_,
P_NN
=_JJ
.2_NN
-RRB-_-RRB-
._.

Thrombin_NN
activation_NN
was_VBD
also_RB
seen_VBN
with_IN
apoptotic_JJ
human_JJ
VSMCs_NNS
-LRB-_-LRB-
AUC_NN
of_IN
211_CD
+_NN
\/_:
-_CC
8_CD
nmol_NN
x_CC
min\/L_NN
;_:
PT_NN
of_IN
103_CD
+_CC
\/_JJ
-_:
4_CD
nmol\/L_NN
-RRB-_-RRB-
and_CC
was_VBD
inhibited_VBN
by_IN
annexin_NN
V_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
.0001_CD
for_IN
AUC_NN
and_CC
PT_NN
-RRB-_-RRB-
._.

VSMC-myc_JJ
cells_NNS
maintained_VBN
in_IN
serum_NN
generated_VBD
less_RBR
thrombin_NN
than_IN
after_IN
serum_NN
withdrawal_NN
-LRB-_-LRB-
P_NN
=_JJ
.0002_NN
for_IN
AUC_NN
and_CC
PT_NN
-RRB-_-RRB-
._.

VSMCs_NNS
derived_VBN
from_IN
human_JJ
coronary_JJ
atherosclerotic_JJ
plaques_NNS
that_WDT
apoptose_VBP
even_RB
in_IN
serum_NN
also_RB
generated_VBD
thrombin_NN
-LRB-_-LRB-
AUC_NN
of_IN
260_CD
+_NN
\/_:
-_CC
2_CD
nmol_NN
x_CC
min\/L_NN
;_:
PT_NN
of_IN
128_CD
+_CC
\/_JJ
-_:
4_CD
nmol\/L_NN
-RRB-_-RRB-
._.

We_PRP
conclude_VBP
that_IN
apoptotic_JJ
VSMCs_NNS
possess_VBP
a_DT
significant_JJ
thrombin-generating_JJ
capacity_NN
secondary_JJ
to_TO
phosphatidylserine_NN
exposure_NN
._.

Apoptotic_JJ
cells_NNS
within_IN
atherosclerotic_JJ
plaques_NNS
may_MD
allow_VB
local_JJ
thrombin_NN
activation_NN
,_,
thereby_RB
contributing_VBG
to_TO
disease_NN
progression_NN
._.

